coronary artery disease Aortic valve disease Mitral valve disease Tricuspidal valve disease or combination of the above
Conditions
Brief summary
Nightly pulse oximetry desaturations: amount, depth, and time of recovery heir duration and respiratory rate. The connection of these changes to use of oxycodone PCA use.
Detailed description
Pain after cardiac surgery, morbidity, anxiety and depression, resilience, life satisfaction and heath related quality of life, Pain assessment daily with NRS at the hospital, Surgical complications with Clavien-Dindo classification, Pain outside hospital with Brief Pain Inventory (BPI)
Interventions
DRUGPanadol Forte 1000 mg tabletti
DRUGOxanest® 10 mg/ml injektionsvätska
DRUGlösning
Sponsors
Pohjois-Savon hyvinvointialue
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nightly pulse oximetry desaturations: amount, depth, and time of recovery heir duration and respiratory rate. The connection of these changes to use of oxycodone PCA use. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain after cardiac surgery, morbidity, anxiety and depression, resilience, life satisfaction and heath related quality of life, Pain assessment daily with NRS at the hospital, Surgical complications with Clavien-Dindo classification, Pain outside hospital with Brief Pain Inventory (BPI) | — |
Countries
Finland
Outcome results
None listed